Relenza (zanamivir), Glaxo Wellcome's much maligned antiflu drug, has received another knock in the medical press. This time, studies show that the product is too difficult for elderly people to u ...
Relenza (zanamivir), Glaxo Wellcome's much maligned antiflu drug, has received another knock in the medical press. This time, studies show that the product is too difficult for elderly people to u ...